Who
Terilyn J. Monroe
Chief People Officer
Company insider
Files Form 4 as: Chief People Officer, Guardant Health; Chief People & Culture Officer, LiveRamp Holdings.
In numbers
- Trades disclosed
- 130
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $26.1M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 14 Sep 2015
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —2,659 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,360 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $367K2,098 at $174.75 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —2,659 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,360 at $0.00 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $650K32,288 at $20.14 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $401K14,012 at $28.61 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $605K3,704 at $163.41 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —32,288 at $0.00 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —14,012 at $0.00 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.6M9,934 at $164.27 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $3.1M19,014 at $165.16 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $2.2M13,248 at $166.11 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $67K400 at $167.92 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —32,288 at $0.00 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —14,012 at $0.00 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $650K32,288 at $20.14 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $401K14,012 at $28.61 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $605K3,704 at $163.41 | filing |
| 12 Aug 2026filed 13 Aug 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.6M9,934 at $164.27 | filing |
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026Guardant Health (NASDAQ:GH) Director Sells $19,242.08 in StockGH · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Terilyn J. Monroe; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.